… of efficacious and safe systemic therapies for the treatment of moderate-to-severe psoriasis
and active psoriatic arthritis… proposed molecular mechanisms of action, efficacy, and safety of …

Psoriatic arthritis (PsA) is a large volume of our clinical practice and its management can be
challenging. Traditional DMARDs have been used over last six decades and observational …

… Figure 2 depicts a crude summary on the efficacy results of interventions by mode of action
and disease domain. Most RCTs were regarded to have low RoB, while unclear RoB was …

… (EULAR) recommendations for the pharmacological treatment of psoriatic arthritis (PsA). …
are proposed as initial therapy; for patients with arthritis and poor prognostic factors, such as …

… patients, but bDMARDs with different mechanisms of action may be superior alternatives. …
) have either demonstrated limited evidence of efficacy or failed to demonstrate consistent …

… with disease modifying drugs -- comparison of drugs and adverse reactions. J Rheumatol …
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the …

… of efficacy in treating spinal symptoms where conventional DMARDs show little efficacy.6 …
patients in Europe, and all show equivalent efficacy in the treatment of joint disease.1 ,7 – 9 …

… the targeted therapies discussed in this review with their corresponding mode of action. …
efficacy and safety of implementing dual cytokine inhibition in the setting of psoriatic arthritis [32]. …

… Therapeutic approaches for psoriatic arthritis (PsA) include non-… on efficacy of tofacitinib
in the treatment of PsA, giving special attention to non-skin manifestations (peripheral arthritis, …

… /abstracts focused on 3 drugs with new modes of action: ustekinumab (UST), secukinumab
(… of the present review (psoriatic arthritis long-term assessment of clinical efficacy; PALACE-1)…